This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Have Conflicting Sentiments on These Healthcare Companies: Joint (JYNT) and Codexis (CDXS)

Tipranks - Tipranks - Tue Apr 28, 9:32AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Joint (JYNT) and Codexis (CDXS).

Claim 55% Off TipRanks

Joint (JYNT)

In a report released today, Jeremy Hamblin from Craig-Hallum maintained a Hold rating on Joint. The company’s shares closed last Monday at $9.17.

According to TipRanks.com, Hamblin is a 4-star analyst with an average return of 8.5% and a 50.7% success rate. Hamblin covers the NA sector, focusing on stocks such as Lucky Strike Entertainment, Savers Value Village Inc., and Red Robin Gourmet. ;'>

The word on The Street in general, suggests a Hold analyst consensus rating for Joint with a $9.85 average price target, implying a 9.3% upside from current levels. In a report issued on April 25, TipRanks – xAI also reiterated a Hold rating on the stock with a $9.00 price target.

See the top stocks recommended by analysts >>

Codexis (CDXS)

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Codexis. The company’s shares closed last Monday at $2.81, close to its 52-week low of $2.43.

According to TipRanks.com, Hewitt ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -6.5% and a 36.7% success rate. Hewitt covers the Healthcare sector, focusing on stocks such as Maravai Lifesciences Holdings, Park Dental Partners, Inc., and Dyadic International. ;'>

Codexis has an analyst consensus of Strong Buy, with a price target consensus of $6.38, implying a 145.4% upside from current levels. In a report issued on April 24, Piper Sandler also maintained a Buy rating on the stock with a $9.00 price target.

Read More on JYNT:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).